We are live on
!
Find out more
RCM
RA Capital Management Portfolio holdings
AUM
$9.44B
1-Year Est. Return
157.3%
This Fund
S&P 500
This Quarter
Est. Return
+8.63%
1 Year Est. Return
+157.3%
3 Year Est. Return
+589.39%
5 Year Est. Return
+654.96%
10 Year Est. Return
+50,915.53%
AUM
$9.44B
AUM Growth
-$323M
(-3.3%)
Cap. Flow
-$311M
Cap. Flow
% of AUM
-3.3%
Top 10 Holdings %
Top 10 Hldgs %
61.29%
Holding
95
New
24
Increased
17
Reduced
2
Closed
10
Top Buys
| 1 |
SGP
SpyGlass Pharma
SGP
|
+$216M |
| 2 |
Wave Life Sciences
WVE
|
+$114M |
| 3 |
Zai Lab
ZLAB
|
+$106M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$75.5M |
| 5 |
Nuvalent
NUVL
|
+$66.7M |
Top Sells
| 1 |
CDTX
Cidara Therapeutics
CDTX
|
+$743M |
| 2 |
RNAM
Avidity Biosciences
RNAM
|
+$623M |
| 3 |
ACLX
Arcellx
ACLX
|
+$82.6M |
| 4 |
BLTE
Belite Bio
BLTE
|
+$69.2M |
| 5 |
Invivyd
IVVD
|
+$42.3M |
Sector Composition
| 1 | Healthcare | 99.71% |
| 2 | Financials | 0.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCSC
76
Perceptive Capital Solutions
PCSC
$124M
| $8.23M | 0.09% |
750,000
| – | – |
|
77
Adicet Bio
ACET
$81.2M
| $8.05M | 0.09% |
1,182,624
+234,375
| +25% | +$1.75M |
|
78
NewAmsterdam Pharma Warrant
NAMSW
$93.9M
| $6.68M | 0.07% |
333,333
| – | – |
|
79
Corvus Pharmaceuticals
CRVS
$1.27B
| $6.58M | 0.07% |
+450,000
| New | +$7.18M |
|
80
Rani Therapeutics
RANI
$76.8M
| $6.25M | 0.07% |
8,500,000
| – | – |
|
81
Equillium
EQ
$160M
| $6.19M | 0.07% |
+3,096,336
| New | +$5.09M |
|
82
Werewolf Therapeutics
HOWL
$17.1M
| $5.56M | 0.06% |
6,681,307
| – | – |
|
83
MacroGenics
MGNX
$270M
| $5.39M | 0.06% |
+1,864,176
| New | +$3.98M |
|
|
MPLT
84
MapLight Therapeutics
MPLT
$1.66B
| $5.05M | 0.05% |
+248,294
| New | +$4.44M |
|
|
PTN
85
Palatin Technologies
PTN
$16M
| $1.22M | 0.01% |
70,000
| – | – |
|
|
ACLX
86
DELISTED
Arcellx
ACLX
| – | – |
-1,267,156
| Closed | -$82.6M |
|
|
BLTE
87
Belite Bio
BLTE
$5.92B
| – | – |
-432,484
| Closed | -$69.2M |
|
|
CDTX
88
DELISTED
Cidara Therapeutics
CDTX
| – | – |
-3,365,523
| Closed | -$743M |
|
89
Health Catalyst
HCAT
$174M
| – | – |
-793,749
| Closed | -$1.9M |
|
|
90
Invivyd
IVVD
$232M
| – | – |
-17,119,096
| Closed | -$42.3M |
|
91
OrthoPediatrics
KIDS
$509M
| – | – |
-109,959
| Closed | -$1.95M |
|
92
Progyny
PGNY
$2.54B
| – | – |
-96,628
| Closed | -$2.48M |
|
93
Qiagen
QGEN
$8.59B
| – | – |
-43,976
| Closed | -$2.08M |
|
|
RNAM
94
DELISTED
Avidity Biosciences
RNAM
| – | – |
-8,641,031
| Closed | -$623M |
|
|
MDLN
95
Medline Inc
MDLN
$33.2B
| – | – |
-335,000
| Closed | -$14.1M |
|
Similar funds
SCM
AIM
MIF
SIM
NPT
AC
PVI
WPL